Medical Treatment & Prevention
Description
No matching items found.
People
Publications
- ● Sitting Posture Detection and Classification Using Machine Learning Algorithms on RapidMiner; Sri-ngernyuang, C., Prakrankiat Youngkong, et al.; 2025; Journal article
- ● Suppression of the inflammatory response by oxyresveratrol from the root bark of Artocarpus lakoocha Roxb against ultraviolet B-induced keratinocytes mediated by regulating p38 MAPK and AP-1; Kittiya Malaniyoma, Piyanee Ratanachamnongb, Poommaree Namchaiwc, et al.; 2024; Journal article
- ● Synthesis and anti-cancer activities of the stereoisomers of cordyceamide A in a skin carcinoma cell line; Suppakorn Netmanee, Satapanawat Sittihan, Teeraphan Laomettachit, et al.; 2023; Conference proceedings article
- ● Synthesis and cytotoxic evaluation of usnic acid benzylidene derivatives as potential anticancer agents; Huynh T.T.L., Nguyen T.P., Niamnont N., et al.; 2021; Journal article
- ● The Evaluation of Degree of Monomer Conversion, Biaxial Flexural Strength, and Surface Mineral Precipitation of Orthodontic Adhesive Containing Sr-Bioactive Glass Nanoparticles, Calcium Phosphate, and Andrographolide; Wirinrat Chaichana, Supachai Chanachai, Kanlaya Insee, et al.; 2025; Journal article
Projects
- ● Characterizing tissue biomechanical properties for development of artificial tissue; TEERANOOT CHANTHASOPEEPHAN - Department of Mechanical Engineering
- ● Cosmeceutical mask sheet for skin care whitening and antiaging agent using innovative cellulose acetate electrospun fibers doped with a natural oxyresveratal ; NAKORN NIAMNONT - Department of Chemistry
- ● Development of a phototriggerable liposomal delivery system for emblica fruit extract for the treatment of psoriasis; KWANCHANOK PASUWAT - Department of Chemical Engineering
- ● Development of nanobodies specific to the CHRD domain of proprotein convertase subtilisin/kexin type 9 (PCSK9) as biologics for treatment of high blood LDL-cholesterol level; DUJDUAN WARAHO - Faculty of Engineering
- ● Development of nanobody specific to receptor binding domain of SARS-CoV-2 for applying as antibody drug for COVID-19 treatment; DUJDUAN WARAHO - Faculty of Engineering












